These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16299127)

  • 41. miRNA involvement in angiogenesis in age-related macular degeneration.
    Wang L; Lee AY; Wigg JP; Peshavariya H; Liu P; Zhang H
    J Physiol Biochem; 2016 Dec; 72(4):583-592. PubMed ID: 27349759
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inflammation in the pathogenesis of age-related macular degeneration.
    Kanda A; Abecasis G; Swaroop A
    Br J Ophthalmol; 2008 Apr; 92(4):448-50. PubMed ID: 18369057
    [No Abstract]   [Full Text] [Related]  

  • 43. Genetic Variants and Systemic Complement Activation Levels Are Associated With Serum Lipoprotein Levels in Age-Related Macular Degeneration.
    Paun CC; Ersoy L; Schick T; Groenewoud JM; Lechanteur YT; Fauser S; Hoyng CB; de Jong EK; den Hollander AI
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7766-73. PubMed ID: 26641553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relation between size at birth and risk of age-related macular degeneration.
    Hall NF; Gale CR; Syddall H; Martyn CN; Phillips DI
    Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3641-5. PubMed ID: 12454030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Recent advances in the study of blindness].
    Salamanca-Gómez F
    Gac Med Mex; 1998; 134(5):619-20. PubMed ID: 9842146
    [No Abstract]   [Full Text] [Related]  

  • 46. Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6.
    Haines JL; Schnetz-Boutaud N; Schmidt S; Scott WK; Agarwal A; Postel EA; Olson L; Kenealy SJ; Hauser M; Gilbert JR; Pericak-Vance MA
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):329-35. PubMed ID: 16384981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum levels of lipid metabolites in age-related macular degeneration.
    Orban T; Johnson WM; Dong Z; Maeda T; Maeda A; Sakai T; Tsuneoka H; Mieyal JJ; Palczewski K
    FASEB J; 2015 Nov; 29(11):4579-88. PubMed ID: 26187344
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum antioxidants and age-related macular degeneration in a population-based case-control study.
    Mares-Perlman JA; Brady WE; Klein R; Klein BE; Bowen P; Stacewicz-Sapuntzakis M; Palta M
    Arch Ophthalmol; 1995 Dec; 113(12):1518-23. PubMed ID: 7487619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic research provides insights into age-related macular degeneration.
    Hampton T
    JAMA; 2010 Oct; 304(14):1541-3. PubMed ID: 20940375
    [No Abstract]   [Full Text] [Related]  

  • 50. Retinal Cholesterol Content Is Reduced in Simvastatin-Treated Mice Due to Inhibited Local Biosynthesis Albeit Increased Uptake of Serum Cholesterol.
    Mast N; Bederman IR; Pikuleva IA
    Drug Metab Dispos; 2018 Nov; 46(11):1528-1537. PubMed ID: 30115644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group.
    Arch Ophthalmol; 1993 Jan; 111(1):104-9. PubMed ID: 7678730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Associations of cigarette smoking but not serum fatty acids with age-related macular degeneration in a Japanese population.
    Kabasawa S; Mori K; Horie-Inoue K; Gehlbach PL; Inoue S; Awata T; Katayama S; Yoneya S
    Ophthalmology; 2011 Jun; 118(6):1082-8. PubMed ID: 21514959
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The assessment of the lipidogram and the proteinogram profile in patients with nonexudative age-related macular degeneration (AMD)].
    Król W; Smuzyńska M
    Wiad Lek; 2007; 60(9-10):415-7. PubMed ID: 18350713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Genotyping in progressive age-related macular degeneration].
    Calugaru D
    Oftalmologia; 2012; 56(4):15-8. PubMed ID: 23755512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for age-related maculopathy are associated with a relative lack of macular pigment.
    Nolan JM; Stack J; O' Donovan O; Loane E; Beatty S
    Exp Eye Res; 2007 Jan; 84(1):61-74. PubMed ID: 17083932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene-Diet Interactions in Age-Related Macular Degeneration.
    Rowan S; Taylor A
    Adv Exp Med Biol; 2016; 854():95-101. PubMed ID: 26427399
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The challenge of predicting macular degeneration.
    Feigl B; Morris CP
    Curr Med Res Opin; 2011 Sep; 27(9):1745-8. PubMed ID: 21777160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of serum lipids in patients with age related macular degeneration from Pakistan.
    Ambreen F; Khan WA; Qureshi N; Qureshi IZ
    J Pak Med Assoc; 2014 Jun; 64(6):664-9. PubMed ID: 25252486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An Eye on Age-Related Macular Degeneration: The Role of MicroRNAs in Disease Pathology.
    Berber P; Grassmann F; Kiel C; Weber BH
    Mol Diagn Ther; 2017 Feb; 21(1):31-43. PubMed ID: 27658786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The challenge of modeling macular degeneration in mice.
    Marmorstein AD; Marmorstein LY
    Trends Genet; 2007 May; 23(5):225-31. PubMed ID: 17368622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.